Colon cancer warning signal should never be ignored

Share This Post

According to the CDC, colorectal cancer is the third most common cancer diagnosed in the United States and the second leading cause of cancer death in the United States.

You might think this is a problem for the elderly, but more and more adults in their 20s and 30s are diagnosed with colorectal cancer .

Here are six symptoms you should not ignore:

  1. bleeding

The most common warning sign is rectal bleeding.When the toilet You may find toilet paper, toilet inside or feces in mixed with blood, blood may be bright red or deep maroon.

  1. Iron deficiency anemia

When the junction straight while bleeding colorectal tumors, the body will lead to loss of iron. People often are not conscious that they’re bleeding, but routine blood tests will discover anemia, red blood cells or healthy reduction.

  1. Abdominal pain

The tumor may cause blockage or tearing, causing cramps and other pain. The pain may be the intestinal barrier signs also may experience nausea, vomiting and abdominal distension.

4.Feces become narrow

Doctors call this a change in stool caliber. If your stool is often thinner than before, this may indicate a tumor in the colon. Pay attention to other changes in bowel habits, such as constipation.

5.Invalid defecation feeling

Feel themselves must discharge it, but when you try,but no stool. This may be caused by a tumor in the rectum.

  1. Unexplained weight loss

I feel like I have eaten enough, but colorectal cancer can change the way your body eats nutrients, preventing you from absorbing all the nutrients and causing weight loss.

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Risk of developing secondary tumors following CAR-T cell therapy is minimal - A Stanford Study
CAR T-Cell therapy

Risk of developing secondary tumors following CAR-T cell therapy is minimal – A Stanford Study

CAR-T cell therapy, a groundbreaking cancer treatment, carries a risk of developing secondary tumors. This occurs due to the therapy’s potential to cause genetic mutations or alter the immune system’s regulation. Secondary malignancies can arise from these changes, presenting a significant long-term risk for patients. Continuous monitoring and research are crucial to understanding and mitigating these risks, ensuring safer outcomes for those undergoing CAR-T cell therapy.

Seattle Children's Hospital to Start CAR T-Cell Clinical Trial for Pediatric Lupus Patients
CAR T-Cell therapy

Seattle Children’s Hospital to Start CAR T-Cell Clinical Trial for Pediatric Lupus Patients

Seattle Children’s Hospital is launching a groundbreaking CAR T-cell clinical trial for pediatric lupus patients. This innovative approach harnesses the body’s immune cells to target and eliminate lupus-affected cells, offering new hope for young patients with this autoimmune disorder. The trial represents a significant advancement in lupus treatment, aiming to improve outcomes and reduce long-term complications for children suffering from this challenging condition.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) Cancer treatment abroad?
2) CAR T-Cell therapy
3) Cancer vaccine
4) Online video consultation
5) Proton therapy